James Philip Pearson,Todd G. Milne,Thomas Henry Johnston,Jonathan Michael Brotchie
申请号：
US13520644
公开号：
US20130150346A1
申请日:
2011.01.07
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The present disclosure relates to methods of using fatty acid amide hydrolase (FAAH) inhibitors to treat aspects of Parkinsons disease (PD), restless legs syndrome (RLS) and periodic limb movement disorder (PLMD), the use of FAAH inhibitors for the manufacture of medicaments for use in the treatment of PD, RLS and PLMD, as well as pharmaceutically acceptable compositions comprising FAAH inhibitors for use in the treatment of PD, RLS and PLMD.
